Has Matthew Bernabei, MD received payments from drug or device companies?

Yes. Drug and device makers reported $52,192 in general payments to Matthew Bernabei, MD across 141 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Bernabei, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Bernabei, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Bernabei, MD

Clinical Cardiac Electrophysiology · Lancaster, PANPI 1821056771

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $32,263 of the $52,192 with a category attached, or 61.8%. Abbott accounts for 65.0% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $15,267, 6.6 times the $2,319 reported in 2019.

$52,192in general payments, 2019–2025

Across 141 payments — averaging $370.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$34K
Medtronic$15K
Boston Scientific$2K
Medical Device Business Services, Inc.$705
Biosense Webster, Inc.$296
Biotronik Inc.$116
plus $78 from 2 others

$320,977in research payments, 2019–2025

Across 103 payments — averaging $3116.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$173K
Medtronic$112K
Impulse Dynamics (USA) Inc.$32K
E.r. Squibb & Sons, L.L.C.$4K

What the payments were for

Consulting fees$32,26362%
Speaking & faculty fees$9,90019%
Travel & lodging$5,20510%
Food & beverage$4,8259%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	73	$33,919
Medtronic(2 entities)	29	$14,911
Boston Scientific	17	$2,166
Medical Device Business Services, Inc.	5	$705
Biosense Webster, Inc.	10	$296
Biotronik Inc.	2	$116
Acutus Medical, Inc.	4	$59
Abiomed	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACCENT$13,750
AVEIR$8,440
SelectSecure$6,971
Accent Pacemaker$6,175
TENDRIL$1,479
Watchman$877
Agilis NxT EP Introducer$850
THORATEC HEARTMATE 3 LVAS IMPLANT KIT$825
Carto 3 System$597
CardioMEMS HF System$525
Tendril Pacing Lead$425
Quadra Assura CRT Defibrillator$247
QUADRA ASSURA$223
AFFERA MAPPING SYSTEM$172
Farapulse$150
WATCHMAN FLX$145
AZURE XT DR MRI SURESCAN$113
THERMOCOOL SMARTTOUCH$101

How this compares

$52,192 in reported general payments places this provider in the 75th percentile of 201 clinical cardiac electrophysiology providers in Pennsylvania.

See all clinical cardiac electrophysiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$351,868

Medicare patients

2,159

Services billed

4,323

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	94	$88,975
Amiodarone Hcl	92	$4,902
Flecainide Acetate	12	$1,379
Metoprolol Succinate	53	$681
Diltiazem 24hr Er (Cd)Diltiazem Hcl	36	$562
Metoprolol Tartrate	93	$432
Digoxin	31	$332
SotalolSotalol Hcl	22	$175
Pantoprazole Sodium	27	$144
Warfarin Sodium	19	$103
Carvedilol	22	$35
Lisinopril	18	$35
Furosemide	17	$18

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Lancaster

Seth WorleyLancaster$3.7M
Sandeep BansalLancaster$100K
Choudhary ChahalLancaster$52K
Jeffrey ArklesLancaster$48K
John ChenaridesPittsburgh$750K
Fermin GarciaPhiladelphia$684K
Ralph VerdinoPhiladelphia$682K
Pugazhendhi VijayaramanWilkes Barre$594K
Pasquale SantangeliPhiladelphia$581K
Joshua SilversteinPittsburgh$557K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →